Development and validation of a method for analysis of 25 cannabinoids in oral fluid and exhaled breath condensate
Analytical and Bioanalytical Chemistry · 2024
DOI: 10.1007/s00216-024-05369-8 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Analytical and Bioanalytical Chemistry, 2024. Verfasst von Meena Swaminathan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry & Biochemistry, Florida International University, 11200 SW 8th St., Miami, FL, 33199, USA. Hauptthemen laut MEDLINE: Cannabinoids, Breath Tests, Saliva, Limit of Detection. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Institute of Justice.
Abstract (Originalsprache)
Currently, there is a significant demand in forensic toxicology for biomarkers of cannabis exposure that, unlike ∆9-tetrahydrocannabinol, can reliably indicate time and frequency of use, be sampled with relative ease, and correlate with impairment. Oral fluid (OF) and exhaled breath condensate (EBC) are alternative, non-invasive sample matrices that hold promise for identifying cannabis exposure biomarkers. OF, produced by salivary glands, is increasingly utilized in drug screening due to its non-invasive collection and is being explored as an alternative matrix for cannabinoid analysis. EBC is an aqueous specimen consisting of condensed water vapor containing water-soluble volatile and non-volatile components present in exhaled breath. Despite potential advantages, there are no reports on the use of EBC for cannabinoid detection. This study developed a supported liquid extraction approach and LC-QqQ-MS dMRM analytical method for quantification of 25 major and minor cannabinoids and metabolites in OF and EBC. The method was validated according to the ANSI/ASB 036 standard and other published guidelines. LOQ ranged from 0.5 to 6.0 ng/mL for all cannabinoids in both matrices. Recoveries for most analytes were 60-90%, with generally higher values for EBC compared to OF. Matrix effects were observed with some cannabinoids, with effects mitigated by use of matrix-matched calibration. Bias and precision were within ± 25%. Method applicability was demonstrated by analyzing ten authentic OF and EBC samples, with positive detections of multiple analytes in both matrices. The method will facilitate comprehensive analysis of cannabinoids in non-invasive sample matrices for the development of reliable cannabis exposure biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry & Biochemistry, Florida International University, 11200 SW 8th St., Miami, FL, 33199, USA.
- Department of Chemistry & Biochemistry and Global & Forensic Justice Center, Florida International University, Miami, FL, 33199, USA.
- Department of Chemistry & Biochemistry, Florida International University, 11200 SW 8th St., Miami, FL, 33199, USA. adecapr@fiu.edu.
- Department of Chemistry & Biochemistry and Global & Forensic Justice Center, Florida International University, Miami, FL, 33199, USA. adecapr@fiu.edu.
Förderung
- National Institute of Justice
Zitieren
APA
Swaminathan, M., Tarifa, A., & DeCaprio, A. P. (2024). Development and validation of a method for analysis of 25 cannabinoids in oral fluid and exhaled breath condensate. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-024-05369-8
Vancouver
Swaminathan M, Tarifa A, DeCaprio AP. Development and validation of a method for analysis of 25 cannabinoids in oral fluid and exhaled breath condensate. Analytical and Bioanalytical Chemistry. 2024. doi:10.1007/s00216-024-05369-8
BibTeX
@article{Swaminathan2024,
author = {Swaminathan, Meena and Tarifa, Anamary and DeCaprio, Anthony P},
title = {Development and validation of a method for analysis of 25 cannabinoids in oral fluid and exhaled breath condensate},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
doi = {10.1007/s00216-024-05369-8}
}
EUVIMED